Enovix (ENVX) Is Up 17.0% After Q3 Revenue Surge Amid Scale-Up Risks Has The Bull Case Changed?

• In recent months, Enovix reported Q3 2025 revenue of US$8.0 million, reflecting very large year-on-year growth, while its Chief Accounting Officer Kristina Truong sold shares to cover tax obligations from restricted stock units.
• At the same time, the company’s push to prove large-scale manufacturing of its silicon-anode batteries, alongside ongoing execution challenges and production delays, has become a central focus for investors assessing its progress.
• Next, we’ll examine how Enovix’s strong recent revenue performance amid ongoing scale-up and execution risks shapes its existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Enovix Investment Narrative Recap

To own Enovix, you need to believe its silicon anode technology can move from promising engineering to reliable high volume production for smartphones and other devices. The Q3 2025 revenue of US$8.0 million helps confidence in commercial traction, but the key short term catalyst and biggest risk both remain tied to proving it can manufacture at scale, so the recent tax related share sale by the Chief Accounting Officer is not a material change to that thesis.

The most relevant recent update is Enovix’s Q3 2025 report, which paired strong year on year revenue growth with a wider quarterly net loss of US$53.7 million. That combination keeps the focus squarely on whether upcoming manufacturing milestones and customer qualifications can eventually offset continued losses and high capital needs as the company pushes toward larger programs in smartphones and wearables.

Yet behind the revenue momentum, investors should be aware of how sensitive the story still is to potential production delays...

Read the full narrative on Enovix (it's free!)

Enovix's narrative projects $460.3 million revenue and $48.3 million earnings by 2028.

Uncover how Enovix's forecasts yield a $26.90 fair value, a 210% upside to its current price.

Exploring Other Perspectives

Eight fair value estimates from the Simply Wall St Community span roughly US$0.80 to US$35 per share, highlighting very different expectations. You can weigh those views against Enovix’s execution risk around scaling smartphone battery production, which could have a significant impact on how its progress is ultimately judged.

Explore 8 other fair value estimates on Enovix - why the stock might be worth over 4x more than the current price!

Build Your Own Enovix Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Enovix research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Enovix research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Enovix's overall financial health at a glance.

Ready For A Different Approach?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• The latest GPUs need a type of rare earth metal called Terbium and there are only 39 companies in the world exploring or producing it. Find the list for free.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com